CD276 and breast carcinoma: examined the role of B7-H3 in paclitaxel resistance in several metastatic breast cancer cell lines; their results indicated that the B7-H3-shRNA-induced knockdown of the B7-H3 protein in these cells resulted in increased sensitivity to paclitaxel (65).